$17.73▲1.03 (6.17%)
After Hours:$17.73+0.00 (+0.00%)· 4:32 PM ET
Ultragenyx Pharmaceutical Inc. (RARE)
Long-Term Debt
$1.11B
Quarterly · Period ending: · USD

RARE Long-Term Debt
Latest reported$1.20Bperiod ending
Latest reported$1.20Bperiod ending
RARE FY Long-Term Debt ($0.00 → $1.20B)
Annual long-term debt
High-resolution chart · PNG
What is long-term debt?
Debt obligations due beyond one year.
RARE long-term debt history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Debt (USD) |
|---|---|
| 1,195,000,000 | |
| 30,042,000 | |
| 30,574,000 | |
| 19,814,000 | |
| 30,904,000 | |
| 39,251,000 | |
| 29,757,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance